Exosome Research Products Market Growth in Next 5 Years
Global Exosome Research Products Market is projected to reach USD 264 million by 2024 from USD 91 million in 2019, at a CAGR of 23.8% during the forecast period.
Global Exosome Research Products Market is projected to reach USD 264 million by 2024 from USD 91 million in 2019, at a CAGR of 23.8% during the forecast period.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Exosome</strong> <strong>Research</strong> <strong>Products</strong> <strong>Market</strong> <strong>Growth</strong> <strong>in</strong><br />
<strong>Next</strong> 5 <strong>Years</strong><br />
<strong>Exosome</strong> <strong>Research</strong> <strong>Products</strong> <strong>Market</strong> by Product and Services (Kit, Reagent, Instrument, Service),<br />
Application (cancer [lung cancer, prostate cancer, breast cancer]), and End User (Hospitals,<br />
Academics, <strong>Research</strong> Institute) - Global Forecast to 2024", published by <strong>Market</strong>sand<strong>Market</strong>s,<br />
Global <strong>Exosome</strong> <strong>Research</strong> <strong>Products</strong> <strong>Market</strong> is projected to reach USD 264 million by 2024 from USD<br />
91 million <strong>in</strong> 2019, at a CAGR of 23.8% dur<strong>in</strong>g the forecast period.<br />
The factors support<strong>in</strong>g market growth <strong>in</strong>clude the <strong>in</strong>creas<strong>in</strong>g fund<strong>in</strong>g for life science research, the<br />
high global prevalence of cancer, and the <strong>in</strong>creas<strong>in</strong>g <strong>in</strong>terest <strong>in</strong> exosome-based procedures.<br />
Browse <strong>in</strong>-depth TOC on "<strong>Exosome</strong> <strong>Research</strong> <strong>Products</strong> <strong>Market</strong>"<br />
74 – Tables<br />
34 – Figures<br />
127 – Pages<br />
The global <strong>Exosome</strong> <strong>Research</strong> <strong>Products</strong> <strong>Market</strong> is segmented <strong>in</strong>to four major regions, namely, North<br />
America, Europe, Asia, and the Rest of the World. In 2018, North America accounted for the largest<br />
share of the market. The large share of the North American market can be attributed to factors<br />
such as the availability of government fund<strong>in</strong>g for life science research, favorable regulatory<br />
environment, <strong>in</strong>creas<strong>in</strong>g focus on exosomes <strong>in</strong> research and diagnostics, and the presence of highquality<br />
<strong>in</strong>frastructure for cl<strong>in</strong>ical and laboratory research.
In 2018, Europe was the second-largest regional market for exosome research products ow<strong>in</strong>g to a<br />
large number of ongo<strong>in</strong>g research studies and <strong>in</strong>creas<strong>in</strong>g government fund<strong>in</strong>g for life science<br />
research activities <strong>in</strong> European countries.<br />
Inquiry Before Buy<strong>in</strong>g:<br />
https://www.marketsandmarkets.com/Enquiry_Before_Buy<strong>in</strong>gNew.asp?id=224782498<br />
The global <strong>Exosome</strong> <strong>Research</strong> <strong>Products</strong> <strong>Market</strong> is highly competitive ow<strong>in</strong>g to the presence of<br />
several large and small players. Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Bio-<br />
Techne (US), System Biosciences, LLC. (US), NX Pharmagen (US), Miltenyi Biotec (Germany), AMS<br />
Biotechnology (Europe) Limited (UK), NanoSomiX (US), Lonza (Switzerland), and Norgen Biotek<br />
Corp. (Canada) are some of the lead<strong>in</strong>g players operat<strong>in</strong>g <strong>in</strong> the global <strong>Exosome</strong> <strong>Research</strong> <strong>Products</strong><br />
<strong>Market</strong>.<br />
To Know More @ https://www.marketsandmarkets.com/<strong>Market</strong>-Reports/exosome-researchproduct-market-224782498.html
Change language